|1.||Rubovitch, Vardit: 2 articles (01/2004 - 01/2003)|
|2.||Gafni, Mikhal: 2 articles (01/2004 - 01/2003)|
|3.||Sarne, Yosef: 2 articles (01/2004 - 01/2003)|
|4.||Bash, Roni: 1 article (01/2003)|
|5.||Meschler, J P: 1 article (11/2000)|
|6.||Kraichely, D M: 1 article (11/2000)|
|7.||Wilken, G H: 1 article (11/2000)|
|8.||Howlett, A C: 1 article (11/2000)|
01/01/2003 - "The present study expands our previous findings and demonstrates that, in N18TG2 neuroblastoma cells, the cannabinoid agonist desacetyllevonantradol (DALN) stimulates both cAMP formation and Ca(2+) uptake. "
01/05/2004 - "In a previous study, we demonstrated a stimulatory effect of the synthetic cannabinoid receptor agonist desacetyllevonantradol (DALN) on Ca(2+) flux into N18TG2 neuroblastoma cells, and suggested a dual mechanism: one pathway mediated by PKA and the other one by protein kinase C (PKC). "
11/01/2000 - "SR141716A augmented secretin-stimulated cyclic AMP (cAMP) accumulation in intact N18TG2 neuroblastoma cells, and this response was reversed by the agonist desacetyllevonantradol. "
|1.||Cannabinoid Receptors (Cannabinoid Receptor)
|2.||Protein Kinase C
|4.||Cyclic AMP (AMP, Cyclic)